SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
pages: 1 2
|
presentations:
1 to
50 of
91
|
THE VAGINAL MICROBIOME AND ACQUISITION OF HIV INFECTION (ABSTRACT
64)
Nichole Klatt
University of Washington, Seattle, WA, USA
ADDRESSING MENTAL HEALTH: A CRUCIAL COMPONENT TO ENDING THE HIV EPIDEMIC (ABSTRACT
65)
Robert H. Remien
HIV Center for Clinical & Behavioral Studies, NYS Psychiatric Institute and Columbia University, New York, NY, USA
HIV TREATMENT, PREVENTION, AND INCIDENCE IN A HYPERENDEMIC UGANDAN FISHING COMMUNITY (ABSTRACT
90)
Joseph Kagaayi
Rakai Health Science Program, Kalisizo, Uganda
PROGRESS TOWARD 90-90-90: 2016 LESOTHO POPULATION-BASED HIV IMPACT ASSESSMENT RESULTS (ABSTRACT
91)
Kyaw Thin
Ministry of Health Lesotho, Maseru, Lesotho
CLINICAL PRESENTATION OF HIV DIFFERS BY AGE IN VACS (2010-2015) (ABSTRACT
92)
Amy C. Justice
Veterans Administration Connecticut Healthcare System, West Haven, CT, USA
THE RAPID ART PROGRAM INITIATIVE FOR HIV DIAGNOSES (RAPID) IN SAN FRANCISCO (ABSTRACT
93)
Oliver Bacon
San Francisco Department of Public Health, San Francisco, CA, USA
SAME-DAY ART INITIATION AFTER HOME-BASED HIV TESTING: A RANDOMIZED CONTROLLED TRIAL (ABSTRACT
94)
Niklaus Daniel Labhardt
Swiss Tropical and Public Health Institute, Basel, Switzerland
RANDOMIZED CONTROLLED TRIAL OF FINANCIAL INCENTIVES FOR ACHIEVING VIRAL SUPPRESSION (ABSTRACT
95)
Harsha Thirumurthy
University of Pennsylvania, Philadelphia, PA, USA
EXTENDED-RELEASE NALTREXONE IMPROVES VIRAL SUPPRESSION IN HIV+ PRISONERS (ABSTRACT
96)
Sandra Springer
Yale School of Medicine, New Haven, CT, USA
HIGHER MORTALITY IN HIV - INFECTED VS - UNINFECTED ADULTS DESPITE ART, BOTSWANA (ABSTRACT
97)
Tendani Gaolathe
Botswana-Harvard AIDS Institute, Gaborone, Botswana
IL-6, D-DIMER OR T-CELLS: WHICH BEST PREDICT EVENTS OR EXPLAIN BENEFITS OF EARLY ART? (ABSTRACT
74)
Jason V Baker
HCMC / University of Minnesota, Minneapolis, MN, USA
SERIOUS CLINICAL OUTCOMES IN HIV-POSITIVE PERSONS WITH CHRONIC KIDNEY DISEASE (CKD) (ABSTRACT
75)
Lene Ryom
CHIP, Department of Infectious Diseases, Copenhagen, Denmark
INCREASED RISK OF PERIPHERAL ARTERY DISEASE IN PERSONS WITH HIV COMPARED TO CONTROLS (ABSTRACT
76)
Andreas Dehlbæk Knudsen
Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
HIV INFECTION IS ASSOCIATED WITH PROGRESSION OF HIGH RISK CORONARY PLAQUE IN THE MACS (ABSTRACT
77)
Wendy Post
Johns Hopkins University, Baltimore, MD, USA
CAROTID ARTERY ATHEROSCLEROSIS IS ASSOCIATED WITH MORTALITY IN HIV+ WOMEN AND MEN (ABSTRACT
78)
David B Hanna
Albert Einstein College of Medicine, Bronx, NY, USA
IMPACT OF LDMTX ON IMMUNE ACTIVATION AND ENDOTHELIAL FUNCTION IN TREATED HIV (ABSTRACT
79)
Priscilla Hsue
University of California San Francisco, San Francisco, CA, USA
PLATELET FUNCTION UPON SWITCHING TO TAF VS CONTINUING ABC: A RANDOMIZED SUBSTUDY (ABSTRACT
80)
Patrick W.G. Mallon
University College Dublin, Dublin, Ireland
A TREATMENT AS PREVENTION TRIAL TO ELIMINATE HCV IN HIV+ MSM: THE SWISS HCVREE TRIAL (ABSTRACT
81LB)
Dominique Laurent Braun
University Hospital Zurich, University of Zurich, Zurich, Switzerland
PROTECTION AGAINST REPEATED VAGINAL SHIV CHALLENGES BY BNAB 3BNC117 AND 10-1074 (ABSTRACT
82)
David A Garber
Centers for Disease Control and Prevention, Atlanta, GA, USA
LONG-ACTING CABOTEGRAVIR PROTECTS MACAQUES AGAINST REPEATED PENILE SHIV EXPOSURES (ABSTRACT
83)
Charles Dobard
CDC, atlanta, GA, USA
GRIFFITHSIN/CARRAGEENAN INSERTS PREVENT SHIV, HSV-2, AND HPV INFECTIONS IN VIVO (ABSTRACT
84)
Nina Derby
Population Council, New York, NY, USA
ORAL FTC/TAF COMBINATION PREVENTS VAGINAL SHIV INFECTION IN PIGTAIL MACAQUES (ABSTRACT
85)
Ivana Massud
Centres for Disease Control and Prevention, Atlanta , GA, USA
BY RACE/ETHNICITY, BLACKS HAVE HIGHEST NUMBER NEEDING PREP IN THE UNITED STATES, 2015 (ABSTRACT
86)
Dawn K Smith
Center for Disease Control & Prevention, Atlanta, GA, USA
GETTING TO ZERO NEW HIV DIAGNOSES IN SAN FRANCISCO: WHAT WILL IT TAKE? (ABSTRACT
87)
Susan P. Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
RAPID REDUCTION IN HIV DIAGNOSES AFTER TARGETED PREP IMPLEMENTATION IN NSW, AUSTRALIA (ABSTRACT
88)
Andrew Grulich
University of New South Wales, Sydney, NSW, Australia
LOW DOSE MK-8591 PROTECTS RHESUS MACAQUES AGAINST RECTAL SHIV INFECTION (ABSTRACT
89LB)
Martin Markowitz
Aaron Diamond AIDS Research Center, New York, NY, USA
PERSISTENT DETECTION OF HIV RNA+ CELLS WITH ART STARTED IN FIEBIG 1&2 VS FIEBIG 3-5 (ABSTRACT
66)
Timothy Schacker
University of Minnesota, Minneapolis, MN, USA
CD8+ T CELL RESPONSES IN TREATED HYPERACUTE HIV INFECTION LIMIT HIV RESERVOIR SIZE (ABSTRACT
67)
Zaza Ndhlovu
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
EXPANDED CLONES HARBORING REPLICATION-COMPETENT VIRUS WAX AND WANE OVERTIME (ABSTRACT
68)
Zheng Wang
Johns Hopkins University School of Medicine, Baltimore, MD, USA
DETERMINANTS OF HIV-1 RESERVOIR SIZE AND LONG-TERM DYNAMICS UNDER SUPPRESSIVE ART (ABSTRACT
69LB)
Nadine Bachmann
University Hospital Zurich, Zurich, Switzerland
NO EVIDENCE FOR ONGOING HIV REPLICATION IN LYMPH NODES DURING SUPPRESSIVE ART (ABSTRACT
70)
Mary F Kearney
National Cancer Institute, National Institutes of Health, Frederick, MD, USA
NO RESIDUAL VIRUS REPLICATION IN A RANDOMISED TRIAL OF DOLUTEGRAVIR INTENSIFICATION (ABSTRACT
71)
Thomas Aagaard Rasmussen
Department of Infectious Diseases, Aarhus University Hospital, Denmark, Aarhus N, Denmark
SINGLE ROMIDEPSIN INFUSIONS DO NOT INCREASE HIV EXPRESSION IN PERSONS ON ART (A5315) (ABSTRACT
72)
Deborah McMahon
University of Pittsburgh, Pittsburgh, PA, USA
PGT121 COMBINED WITH GS-9620 DELAYS VIRAL REBOUND IN SHIV-INFECTED RHESUS MONKEYS (ABSTRACT
73LB)
Dan Barouch
Beth Israel Deaconess Medical Center, Boston, MA, USA
THEMED DISCUSSION MODERATOR
Linda Chang
University of Maryland, Baltimore, MD, USA
CEREBRAL GLUTATHIONE METABOLISM IN ACUTE HIV INFECTION AND RESPONSE TO ART (ABSTRACT
437)
Napapon Sailasuta
University of Hawaii, Honolulu, HI, USA
AMYLOID UPTAKE BY PET IMAGING SUGGEST PREMATURE AGING IN OLDER HIV+ INDIVIDUALS (ABSTRACT
438)
Ned W Sacktor
Johns Hopkins University, Baltimore, CA, USA
NEUROIMAGING CORRELATES OF FRAILTY, COGNITION, AND HIV (ABSTRACT
439)
Jeremy Strain
Washington University School of Medicine, St. Louis, MO, USA
SUBCLINICAL GLOBAL AND THALAMIC HYPOMETABOLISM ON FDG-PET IN TREATED HIV+ SUBJECTS (ABSTRACT
440)
Dima A. Hammoud
National Institutes of Health, Bethesda, MD, USA
BRAIN VOLUMES CHANGES AFTER ABC/3TC + EFV OR TDF/FTC + ATV/R AS FIRST-LINE ART (ABSTRACT
425)
Ignacio Pérez-Valero
Hospital La Paz, Madrid, Spain
THEMED DISCUSSION MODERATOR
Gerardo Garcia-Lerma
Centers for Disease Control and Prevention, Atlanta , GA, USA
LOW PREVALENCE OF INTEGRASE STRAND TRANSFER INHIBITORS RESISTANCE ACROSS BOTSWANA (ABSTRACT
542)
Simani Gaseitsiwe
Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana
HIGH LEVEL RESISTANCE TO DOLUTEGRAVIR (DTG) AFTER EMERGENCE OF T97A MUTATION (ABSTRACT
543)
Safia S Kuriakose
Leidos Biomedical Research, Inc, Bethesda, MD, USA
UNINTEGRATED VIRAL DNA INVOLVED IN DOLUTEGRAVIR RESISTANCE (ABSTRACT
544)
Olivier Delelis
École Normale Supérieure de Cachan, Cachan, France
PREVALENCE AND CLINICAL IMPACT OF MINORITY RESISTANT VARIANTS TO INTEGRASE INHIBITORS (ABSTRACT
545)
Thuy Thi Thu Nguyen
Hôpital Pitié-Salpêtrière, Laboratoire de Virologie, PARIS, France
INTEGRASE INHIBITOR RESISTANCE SELECTIONS INITIATED WITH DRUG RESISTANT HIV-1 (ABSTRACT
546)
Kristen Andreatta
Gilead Sciences, Foster City, CA, USA
THEMED DISCUSSION MODERATOR
Eugènia Negredo
Fundació Lluita Contra la Sida, Badalona, Spain
TDF PROPHYLAXIS FOR PMTCT OF HBV: EFFECT ON MATERNAL AND INFANT BONE MINERAL DENSITY (ABSTRACT
720)
Gonzague Jourdain
Institut de recherche pour le développement, Chiang Mai, Chiang Mai, Thailand
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
pages: 1 2
|
presentations:
1 to
50 of
91
|